NPI: 1548299381 · EDISON, NJ 08820 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/02/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/02/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,518 | $728K |
| 2019 | 9,475 | $833K |
| 2020 | 5,462 | $468K |
| 2021 | 3,430 | $390K |
| 2022 | 5,868 | $378K |
| 2023 | 4,963 | $227K |
| 2024 | 1,930 | $150K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,218 | 1,702 | $2.58M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,342 | 379 | $325K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,439 | 468 | $165K |
| 83970 | 365 | 276 | $25K | |
| A4657 | Syringe, with or without needle, each | 2,786 | 816 | $22K |
| J1756 | Injection, iron sucrose, 1 mg | 1,596 | 341 | $18K |
| 85041 | 194 | 191 | $11K | |
| 85048 | 193 | 190 | $11K | |
| 83550 | 102 | 100 | $6K | |
| 83540 | 101 | 99 | $6K | |
| 82728 | 102 | 100 | $6K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 193 | 80 | $59.10 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 15 | 12 | $0.00 |